BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, Menendez JA. Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients. J Clin Med 2020;9:E1770. [PMID: 32517353 DOI: 10.3390/jcm9061770] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Wadhwa K, Pahwa R, Kumar M, Kumar S, Sharma PC, Singh G, Verma R, Mittal V, Singh I, Kaushik D, Jeandet P. Mechanistic Insights into the Pharmacological Significance of Silymarin. Molecules 2022;27:5327. [PMID: 36014565 DOI: 10.3390/molecules27165327] [Reference Citation Analysis]
2 Aryan H, Farahani RH, Chamanara M, Elyasi S, Jaafari MR, Haddad M, Sani AT, Ardalan MA, Mosaed R. Evaluation of the efficacy of oral nano-silymarin formulation in hospitalized patients with COVID-19: A double-blind placebo-controlled clinical trial. Phytother Res 2022. [PMID: 35859298 DOI: 10.1002/ptr.7537] [Reference Citation Analysis]
3 Hamdy R, Mostafa A, Abo Shama NM, Soliman SSM, Fayed B. Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2. Phytother Res 2022. [PMID: 35596627 DOI: 10.1002/ptr.7486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kashyap D, Roy R, Kar P, Jha HC. Plant-derived active compounds as a potential nucleocapsid protein inhibitor of SARS-CoV-2: an in-silico study. J Biomol Struct Dyn 2022;:1-16. [PMID: 35532092 DOI: 10.1080/07391102.2022.2072951] [Reference Citation Analysis]
5 Křen V, Valentová K. Silybin and its congeners: from traditional medicine to molecular effects. Nat Prod Rep 2022. [PMID: 35510639 DOI: 10.1039/d2np00013j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sun M, Zhao H, Jin Z, Lei W, Deng C, Yang W, Lu C, Hou Y, Zhang Y, Tang R, Zhao L, Zhang S, Yang Y. Silibinin protects against sepsis and septic myocardial injury in an NR1H3-dependent pathway. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.05.018] [Reference Citation Analysis]
7 Ayipo YO, Ahmad I, Najib YS, Sheu SK, Patel H, Mordi MN. Molecular modelling and structure-activity relationship of a natural derivative of o-hydroxybenzoate as a potent inhibitor of dual NSP3 and NSP12 of SARS-CoV-2: in silico study. J Biomol Struct Dyn 2022;:1-19. [PMID: 35037841 DOI: 10.1080/07391102.2022.2026818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Bosch-Barrera J, Roqué A, Teixidor E, Carmona-Garcia MC, Arbusà A, Brunet J, Martin-Castillo B, Cuyàs E, Verdura S, Menendez JA. Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin. Pharmaceuticals (Basel) 2021;15:19. [PMID: 35056076 DOI: 10.3390/ph15010019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Naidu SAG, Mustafa G, Clemens RA, Naidu AS. Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against RNA-Dependent RNA Polymerase Complex (nsp7/nsp8/nsp12) of SARS-CoV-2. J Diet Suppl 2021;:1-30. [PMID: 34850656 DOI: 10.1080/19390211.2021.2006387] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Piplani S, Singh PK, Winkler DA, Petrovsky N. Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies. Mol Biomed 2021;2:28. [PMID: 34766004 DOI: 10.1186/s43556-021-00050-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Guo Y, Esfahani F, Shao X, Srinivasan V, Thomo A, Xing L, Zhang X. Integrative COVID-19 biological network inference with probabilistic core decomposition. Brief Bioinform 2021:bbab455. [PMID: 34791019 DOI: 10.1093/bib/bbab455] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Gasparello J, d'Aversa E, Breveglieri G, Borgatti M, Finotti A, Gambari R. In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR. Int Immunopharmacol 2021;101:108201. [PMID: 34653729 DOI: 10.1016/j.intimp.2021.108201] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Sandoval-gallegos EM, Ramírez-moreno E, Vargas-mendoza N, Arias-rico J, Estrada-luna D, Cuevas-cancino JJ, Jiménez-sánchez RC, Flores-chávez OR, Baltazar-téllez RM, Morales-gonzález JA. Phytochemicals and Their Possible Mechanisms in Managing COVID-19 and Diabetes. Applied Sciences 2021;11:8163. [DOI: 10.3390/app11178163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Křen V. Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners. Int J Mol Sci 2021;22:7885. [PMID: 34360650 DOI: 10.3390/ijms22157885] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
15 Naik B, Mattaparthi VSK, Gupta N, Ojha R, Das P, Singh S, Prajapati VK, Prusty D. Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications. J Biomol Struct Dyn 2021;:1-25. [PMID: 34062110 DOI: 10.1080/07391102.2021.1931451] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Fakhri S, Nouri Z, Moradi SZ, Akkol EK, Piri S, Sobarzo-Sánchez E, Farzaei MH, Echeverría J. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates. Molecules 2021;26:2917. [PMID: 34068970 DOI: 10.3390/molecules26102917] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
17 Anand AV, Balamuralikrishnan B, Kaviya M, Bharathi K, Parithathvi A, Arun M, Senthilkumar N, Velayuthaprabhu S, Saradhadevi M, Al-Dhabi NA, Arasu MV, Yatoo MI, Tiwari R, Dhama K. Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2. Molecules 2021;26:1775. [PMID: 33809963 DOI: 10.3390/molecules26061775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
18 Sardanelli AM, Isgrò C, Palese LL. SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome. Molecules 2021;26:1409. [PMID: 33807773 DOI: 10.3390/molecules26051409] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
19 Savant S, Srinivasan S, Kruthiventi AK. Potential Nutraceuticals for COVID-19. NDS 2021;Volume 13:25-51. [DOI: 10.2147/nds.s294231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
20 Fakhri S, Piri S, Majnooni MB, Farzaei MH, Echeverría J. Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach. Front Pharmacol 2020;11:621099. [PMID: 33708124 DOI: 10.3389/fphar.2020.621099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
21 Wu YH, Yeh IJ, Phan NN, Yen MC, Liu HL, Wang CY, Hsu HP. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis. Int J Med Sci 2021;18:1143-52. [PMID: 33526974 DOI: 10.7150/ijms.52256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
22 Sikander M, Malik S, Rodriguez A, Yallapu MM, Narula AS, Satapathy SK, Dhevan V, Chauhan SC, Jaggi M. Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules 2020;25:E5905. [PMID: 33322162 DOI: 10.3390/molecules25245905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
23 Gasparello J, Finotti A, Gambari R. Tackling the COVID-19 "cytokine storm" with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs. Med Hypotheses 2021;146:110415. [PMID: 33422363 DOI: 10.1016/j.mehy.2020.110415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
24 Majnooni MB, Fakhri S, Shokoohinia Y, Kiyani N, Stage K, Mohammadi P, Gravandi MM, Farzaei MH, Echeverría J. Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury. Front Pharmacol 2020;11:588467. [PMID: 33658931 DOI: 10.3389/fphar.2020.588467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
25 Vlachakis D, Papakonstantinou E, Mitsis T, Pierouli K, Diakou I, Chrousos G, Bacopoulou F. Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic. Food Chem Toxicol 2020;146:111805. [PMID: 33038452 DOI: 10.1016/j.fct.2020.111805] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
26 Soni VK, Mehta A, Ratre YK, Tiwari AK, Amit A, Singh RP, Sonkar SC, Chaturvedi N, Shukla D, Vishvakarma NK. Curcumin, a traditional spice component, can hold the promise against COVID-19? Eur J Pharmacol 2020;886:173551. [PMID: 32931783 DOI: 10.1016/j.ejphar.2020.173551] [Cited by in Crossref: 24] [Cited by in F6Publishing: 45] [Article Influence: 12.0] [Reference Citation Analysis]